PERTH, Australia – Australia's Neuclone Pharmaceuticals Ltd. is developing a broad pipeline of biosimilars, and it plans on being a big disrupter to the global pharma market.
PERTH, Australia – Australia's Therapeutic Goods Administration (TGA) is launching a pilot good clinical practices (GCP) program in the hopes of launching a routine GCP inspections program.
PERTH, Australia – Like many Aussie companies, Invion Ltd. started out with some assets that it had a difficult time progressing forward, and it ended up remaking itself into a completely different company with new assets. Now, Melbourne-headquartered Invion plans to enter the clinic early this year with a photosensitizer therapy to treat melanoma.
PERTH, Australia – Like many Aussie companies, Invion Ltd. started out with some assets that it had a difficult time progressing forward, and it ended up remaking itself into a completely different company with new assets. Now, Melbourne-headquartered Invion plans to enter the clinic early this year with a photosensitizer therapy to treat melanoma.
PERTH, Australia – After nearly 40 years, New Zealand is preparing new legislation to regulate drugs and devices that would replace the Medicines Act 1981.
PERTH, Australia – After nearly 40 years, New Zealand is preparing new legislation to regulate drugs and devices that would replace the Medicines Act 1981.
